Research Article
The Clinical and Genetic Characteristics in Children with Idiopathic Hypogonadotropin Hypogonadism
Table 4
Further genetic pathogenicity analysis of 12 children with IHH (excluding benign or likely benign variants).
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
: Splice Site Score Calculation and SpliceAI for Splicing Sites: Test positive. The 12 variants predicted by MutationTaster are all classified as "pathogenic". CADD_raw is the initial score, and CADD_phred is the converted score. The higher the score, the greater the harmful effect.The CADD_phred score is recommended to be greater than 15. MetaSVM fractional cut value is 0.0 (higher score indicates greater harmful effects). ACMG: American College of Medical Genetics Laboratory Practice Committee Working Group, Described as P:pathogenic; LP:likely pathogenic; US: uncertain significance. B: benign ;LB: likely benign. PVS: pathogenic very strong, PS: pathogenic strong, PM: pathogenic moderate,PP: pathogenic supporting. |